213 related articles for article (PubMed ID: 10970729)
21. Detection and Identification of Base Alterations Within the Region of Factor V Leiden by Fluorescent Melting Curves.
Lyondagger E; Millsondagger A; Phan T; Wittwer CT
Mol Diagn; 1998 Dec; 3(4):203-209. PubMed ID: 10089278
[TBL] [Abstract][Full Text] [Related]
22. Phenotyping and genotyping of coagulation factor V Leiden.
Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
[TBL] [Abstract][Full Text] [Related]
23. Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides.
Crockett AO; Wittwer CT
Anal Biochem; 2001 Mar; 290(1):89-97. PubMed ID: 11180941
[TBL] [Abstract][Full Text] [Related]
24. [New DNA diagnostic system for determination and identification of homo- and heterozygote point mutations].
Patrushev LI; Zykova ES; Kaiushin AL; Korosteleva MD; Miroshnikov AI
Bioorg Khim; 1998 Mar; 24(3):194-200. PubMed ID: 9612561
[TBL] [Abstract][Full Text] [Related]
25. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.
van de Locht LT; Kuypers AW; Verbruggen BW; Linssen PC; Nováková IR; Mensink EJ
Thromb Haemost; 1995 Nov; 74(5):1276-9. PubMed ID: 8607109
[TBL] [Abstract][Full Text] [Related]
26. A fast and robust dual-label nonradioactive oligonucleotide ligation assay for detection of factor V Leiden.
Chakravarty A; Hansen TS; Hørder M; Kristensen SR
Thromb Haemost; 1997 Oct; 78(4):1234-6. PubMed ID: 9364990
[TBL] [Abstract][Full Text] [Related]
27. A hemi-nested, allele specific, whole blood PCR assay for the detection of the factor V Leiden mutation.
Sinclair GD; Low S; Poon MC
Thromb Haemost; 1997 Jun; 77(6):1154-5. PubMed ID: 9241749
[TBL] [Abstract][Full Text] [Related]
28. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
[TBL] [Abstract][Full Text] [Related]
29. Electrochemical genosensor based on colloidal gold nanoparticles for the detection of Factor V Leiden mutation using disposable pencil graphite electrodes.
Ozsoz M; Erdem A; Kerman K; Ozkan D; Tugrul B; Topcuoglu N; Ekren H; Taylan M
Anal Chem; 2003 May; 75(9):2181-7. PubMed ID: 12720360
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
31. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
Bouaziz-Borgi L; Almawi WY; Mtiraoui N; Nsiri B; Keleshian SH; Kreidy R; Louzir B; Hezard N; Mahjoub T
Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828
[TBL] [Abstract][Full Text] [Related]
32. Detection of factor V Leiden from a drop of blood by PCR-SSCP.
Corral J; Iniesta JA; González-Conejero R; Vicente V
Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782
[TBL] [Abstract][Full Text] [Related]
33. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
36. [Real time quantitative PCR].
Kim DW
Exp Mol Med; 2001 Apr; 33(1 Suppl):101-9. PubMed ID: 11708318
[TBL] [Abstract][Full Text] [Related]
37. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay.
Patnaik M; Dlott JS; Fontaine RN; Subbiah MT; Hessner MJ; Joyner KA; Ledford MR; Lau EC; Moehlenkamp C; Amos J; Zhang B; Williams TM
J Mol Diagn; 2004 May; 6(2):137-44. PubMed ID: 15096570
[TBL] [Abstract][Full Text] [Related]
38. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
Dindagur N; Kruthika-Vinod TP; Christopher R
Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
[TBL] [Abstract][Full Text] [Related]
39. Universal quenching probe system: flexible, specific, and cost-effective real-time polymerase chain reaction method.
Tani H; Miyata R; Ichikawa K; Morishita S; Kurata S; Nakamura K; Tsuneda S; Sekiguchi Y; Noda N
Anal Chem; 2009 Jul; 81(14):5678-85. PubMed ID: 19530673
[TBL] [Abstract][Full Text] [Related]
40. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
